The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Lamictal 25 mg tablets



PCO Manufacturing Ltd.PPA0465/092/011

Main Information

Trade NameLamictal 25 mg tablets
Active SubstancesLamotrigine
Dosage FormTablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/092/011

Group Information

ATC CodeN03AX Other antiepileptics
N03AX09 lamotrigine

Status

License statusAuthorised
Licence Issued09/05/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back